Icatibant
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 634 publications
Neprilysin Inhibitor and Angiotensin Receptor Blocker Attenuate Ischemic Brain Injury: Unveiling the Kinin-Mediated Pathway.
Journal: Assay and drug development technologies
Published: March 10, 2026
Sebetralstat (Ekterly) for treatment of hereditary angioedema attacks.
Journal: The Medical letter on drugs and therapeutics
Published: February 06, 2026
Halide-Mediated Electrochemical Peptide Synthesis Applicable to Highly Sterically Hindered Amino Acids.
Journal: Organic letters
Published: February 05, 2026
Comparison of Clinical Characteristics Between Hereditary Angioedema Patients Aged 65 Years and Older and Those Under 65: A Perspective on Elderly Patients.
Journal: Life (Basel, Switzerland)
Published: December 18, 2025
Non-peptide bradykinin B2 receptor ligands possessing the substituted quinolinyl moiety: pharmacological properties and prospective clinical uses.
Journal: Peptides
Published: November 18, 2025
Recurrent Airway Swelling in a Patient With Lymphoproliferative Disorder: A Diagnostic Challenge Between Anaphylaxis and Acquired Angioedema.
Journal: Cureus
Published: November 04, 2025
Icatibant Use During Pregnancy: A South African Case Series.
Journal: Journal of investigational allergology & clinical immunology
Published: October 24, 2025
Implementation of genetic diagnosis and personalized management of hereditary angioedema in a Chinese regional center: a community case study of three families.
Journal: Frontiers in allergy
Published: September 08, 2025
Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema Following Long-Term Lisinopril Use: Response to C1 Esterase Inhibitor Treatment.
Journal: Cureus
Published: August 30, 2025
Clinical features of hereditary angioedema involving the gastrointestinal tract: A retrospective analysis.
Journal: The World Allergy Organization journal
Published: July 23, 2025
Last Updated: 04/28/2026